<code id='A92BE54105'></code><style id='A92BE54105'></style>
    • <acronym id='A92BE54105'></acronym>
      <center id='A92BE54105'><center id='A92BE54105'><tfoot id='A92BE54105'></tfoot></center><abbr id='A92BE54105'><dir id='A92BE54105'><tfoot id='A92BE54105'></tfoot><noframes id='A92BE54105'>

    • <optgroup id='A92BE54105'><strike id='A92BE54105'><sup id='A92BE54105'></sup></strike><code id='A92BE54105'></code></optgroup>
        1. <b id='A92BE54105'><label id='A92BE54105'><select id='A92BE54105'><dt id='A92BE54105'><span id='A92BE54105'></span></dt></select></label></b><u id='A92BE54105'></u>
          <i id='A92BE54105'><strike id='A92BE54105'><tt id='A92BE54105'><pre id='A92BE54105'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          entertainment

          author:leisure time    - browse:6838
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus